ALMKT — Mauna Kea Technologies SA Share News
0.000.00%
- €18.03m
- €27.51m
- €8.22m
Brief: Mauna Kea, Tasly Pharmaceutical Announce Incorporation Of JV In China
Brief: Mauna Kea Technologies: Success Of Clinical Trial On Prediction Of Remission In Patients With Inflammatory Bowel Disease
Brief: Mauna Kea Technologies Q3 Total Sales Down At EUR 1.4 Mln
Brief: Mauna Kea Technologies Appoints Sacha Loiseau As CEO
Brief: Mauna Kea Technologies H1 Sales Up At EUR 3.4 Mln
Brief: Mauna Kea Technologies, Tasly Pharmaceuticals Announce JV And Licensing Agreements
Brief: Mauna Kea Updates On Cellvizio In Detection Of Esophageal Dysplasia And Cancer
Brief: Mauna Kea, On Target Laboratories Show New Approach In Lung Cancer Detection
Brief: Mauna Kea Technologies FY Operating Loss Widens To EUR 12.2 Million
Brief: Mauna Kea Announces FDA Clearance For The Use Of Cellvizio
Brief: Mauna Kea Technologies And On Target Laboratories Announce Novel Clinical Research And Product Development Collaboration
Brief: Mauna Kea Technologies Starts Enrollment In Peripheral Lung Cancer Multi-Center Clinical Trial
Brief: Mauna Kea Technologies FY Total Sales Up At 7.70 Million Euros
Brief: Mauna Kea Technologies Cash Balance At 11.8 Million Euros As Of December 31,2021
Brief: Mauna Kea Semiconductors Raises $12.8 Million In Pre-A+ Round
Mauna Kea's strategic realignment lifts shares
Brief: Mauna Kea Technologies Says Nicolas Bouvier Appointed As Interim CEO
Brief: Mauna Kea Q3 Total Sales Down At 1.8 Million Euros
Brief: Mauna Kea Technologies H1 Net Loss Flat at EUR 6.7 Mln